Ciprofloxacin
Showing 1 - 25 of 537
Ciprofloxacin Utilization and Adverse Events Occurrence in
Completed
- Ciprofloxacin Adverse Reaction
- Ciprofloxacin Tablets
-
Damanhūr, Elbehairah, EgyptRehab Hussein Werida
Jun 13, 2023
Surgical Site Infections Trial in Shibin Al Kawm (Ciprodiazole, Ciprofloxacin Tablets & Metronidazole tablets)
Recruiting
- Surgical Site Infections
- Ciprodiazole
- Ciprofloxacin Tablets & Metronidazole tablets
-
Shibīn Al Kawm, Menofia, EgyptFaculty of Medicine - Menofia University
May 8, 2023
Healthy Subjects Trial in Austin (Vorasidenib 40 mg Oral Tablet, Ciprofloxacin 500 mg Oral Tablet, Vorasidenib 10 mg Oral
Recruiting
- Healthy Subjects
- Vorasidenib 40 mg Oral Tablet
- +2 more
-
Austin, TexasPPD Development
May 3, 2023
Leukemia, Acute Myelogenous Leukemia, Acute Myeloid Leukemia Trial in Gainesville (Ciprofloxacin 750 MG, Etoposide,
Terminated
- Leukemia
- +2 more
- Ciprofloxacin 750 MG
- +3 more
-
Gainesville, FloridaUF Health Shands Cancer Hospital
Jul 5, 2022
Acute Lymphoblastic Leukaemia - Category Trial in Leicester (Ciprofloxacin, Antibiotic)
Recruiting
- Acute Lymphoblastic Leukaemia - Category
- Ciprofloxacin
- Antibiotic
-
Leicester, United KingdomLeicester Royal Infirmary
Jul 5, 2022
Patients withInfections Caused by S.Aureus Like Skin Infections , Chest Infections , Surgical Site Infections , and Urinary
Not yet recruiting
- Patients withInfections Caused by S.Aureus Like Skin Infections , Chest Infections , Surgical Site Infections , and Urinary Tract Infections
- antibiotic sensitivity
-
Sohag, EgyptSohag University Hospital
Apr 13, 2023
Pharmacokinetics Trial (PrimeC 748 mg, Ciprofloxacin 750 MG, Celecoxib 200mg)
Not yet recruiting
- Pharmacokinetics
- PrimeC 748 mg
- +2 more
- (no location specified)
Jun 28, 2022
Recurrent Uti Trial in Chicago (Saccharomyces Boulardii 250 MG [Florastor])
Recruiting
- Recurrent Uti
- Saccharomyces Boulardii 250 MG [Florastor]
-
Chicago, IllinoisLurie Children's Hospital
Nov 21, 2023
Bacterial Infections Oral Trial in Cairo (Chitosan Coated PLGA nanoparticles entrapping Ciprofloxacin incorporated in smart
Completed
- Bacterial Infections Oral
- Chitosan Coated PLGA nanoparticles entrapping Ciprofloxacin incorporated in smart gels
- Ciprofloxacin paste and solution
-
Cairo, El Sherouk City , Suez Desert Road , Cairo - P.O. Box 43, EgyptMona Arafa
Jul 23, 2022
Neisseria Gonorrhoeae Infection Trial in Seattle (Ciprofloxacin 500 mg)
Recruiting
- Neisseria Gonorrhoeae Infection
- Ciprofloxacin 500 mg
-
Seattle, WashingtonPublic Health -- Seattle & King County Sexual Health Clinic
Mar 9, 2022
Febrile Neutropenia Trial (Placebo, Amoxicillin Clavulanate, Ciprofloxacin)
Withdrawn
- Febrile Neutropenia
- Placebo
- +2 more
- (no location specified)
Mar 16, 2022
ALS (Amyotrophic Lateral Sclerosis) Trial in Phoenix (Fixed dose combination Ciprofloxacin/Celecoxib)
Completed
- ALS (Amyotrophic Lateral Sclerosis)
- Fixed dose combination Ciprofloxacin/Celecoxib
-
Phoenix, ArizonaBarrow Neurological Institute
Jan 30, 2022
Cholangitis Trial in Amsterdam (very short-course of standard of care antibiotics (24 hours), standard course of standard of
Not yet recruiting
- Cholangitis
- very short-course of standard of care antibiotics (24 hours)
- standard course of standard of care antibiotics (4 to 7 days)
-
Amsterdam, Noord Holland, NetherlandsAmsterdam UMC
Feb 28, 2023
Pharmacokinetics Trial in Fargo (PrimeC-ER 748 mg, Ciprofloxacin 750 MG, Celecoxib 200mg)
Completed
- Pharmacokinetics
- PrimeC-ER 748 mg
- +2 more
-
Fargo, North DakotaNovum
Oct 23, 2022
Febrile Neutropenia Trial in Oviedo (Fosfomycin Calcium)
Recruiting
- Febrile Neutropenia
- Fosfomycin Calcium
-
Oviedo, Asturias, SpainInstituto de Investigación Sanitaria del Principado de Asturias
Apr 4, 2022
Cholera Trial in Dhaka (Ciprofloxacin)
Completed
- Cholera
- Ciprofloxacin
-
Dhaka, BangladeshInternational Centre for Diarrhoeal Disease Research, Bangladesh
Feb 10, 2022
Effective Intracanal Medicaments Against Enterococcus Faecalis Trial (Ibuprofen 400 mg., modified triple antibiotic paste,
Not yet recruiting
- Effective Intracanal Medicaments Against Enterococcus Faecalis
- Ibuprofen 400 mg.
- +3 more
- (no location specified)
Aug 17, 2023
Idiopathic Overactive Bladder, Postoperative Urinary Tract Infection Trial in Edmonton (Ciprofloxacin, Placebo Pill)
Recruiting
- Idiopathic Overactive Bladder
- Postoperative Urinary Tract Infection
- Ciprofloxacin
- Placebo Pill
-
Edmonton, Alberta, CanadaUrogynecology Clinic - Royal Alexandra Hospital
Jan 31, 2023
Appendicitis, Perforated Appendicitis, Ruptured Appendicitis Trial in Ann Arbor (Early Appendectomy, Interval Appendectomy,
Completed
- Appendicitis
- +3 more
- Early Appendectomy
- +2 more
-
Ann Arbor, MichiganUniversity of Michigan
Oct 31, 2022
Urinary Tract Infections, Bacteremia, Antibiotic Resistant Infection Trial (Pivmecillinam and amoxicillin/clavulanic acid,
Not yet recruiting
- Urinary Tract Infections
- +2 more
- Pivmecillinam and amoxicillin/clavulanic acid
- Standard treatment, ciprofloxacin, trimethoprim/sulfamethoxazole or ertapenem depending on susceptibility
- (no location specified)
Nov 18, 2022
Pneumonia Trial in Vienna (Ciprofloxacin, Imipenem)
Completed
- Pneumonia
- Ciprofloxacin
- Imipenem
-
Vienna, AustriaMedical University of Vienna
Aug 31, 2021
Epilepsy Intractable Trial in Sari (Ciprofloxacin Oral Product)
Completed
- Epilepsy Intractable
- Ciprofloxacin Oral Product
-
Sari, Mazandaran, Iran, Islamic Republic ofBu Ali Sina hospital
Jun 4, 2021
Haematological Malignancy, Hypogammaglobulinemia Trial (trimethoprim-sulfamethoxazole (co-trimoxazole), amoxycillin/clavulanic
Not yet recruiting
- Haematological Malignancy
- Hypogammaglobulinemia
- trimethoprim-sulfamethoxazole (co-trimoxazole)
- +2 more
- (no location specified)
Jan 4, 2023